Docetaxel and nab-paclitaxel are safe alternative options for patients with gynecologic malignancies following hypersensitivity reaction to paclitaxel.
Year: 2018
Type: article
Source: PubMed
Authors: R Brightwell, Handel E, K Eng, K Grzankowski, P Frederick, K Odunsi, S Lele
Institution: Roswell Park Comprehensive Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2610684180